BR8001779A - Processo para inibir a secrecao de acido gastrico, composto particularmente eficaz para controlar secrecao gastrica e composicao farmaceutica para inibir a secrecao de acido gastrico e/ou tratar ulcera peptica em mamiferos - Google Patents

Processo para inibir a secrecao de acido gastrico, composto particularmente eficaz para controlar secrecao gastrica e composicao farmaceutica para inibir a secrecao de acido gastrico e/ou tratar ulcera peptica em mamiferos

Info

Publication number
BR8001779A
BR8001779A BR8001779A BR8001779A BR8001779A BR 8001779 A BR8001779 A BR 8001779A BR 8001779 A BR8001779 A BR 8001779A BR 8001779 A BR8001779 A BR 8001779A BR 8001779 A BR8001779 A BR 8001779A
Authority
BR
Brazil
Prior art keywords
secrecation
gastric acid
inhibit
inhibit gastric
secretation
Prior art date
Application number
BR8001779A
Other languages
English (en)
Portuguese (pt)
Inventor
R Alphin
H Munson Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of BR8001779A publication Critical patent/BR8001779A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR8001779A 1979-03-26 1980-03-25 Processo para inibir a secrecao de acido gastrico, composto particularmente eficaz para controlar secrecao gastrica e composicao farmaceutica para inibir a secrecao de acido gastrico e/ou tratar ulcera peptica em mamiferos BR8001779A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
BR8001779A true BR8001779A (pt) 1980-11-18

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8001779A BR8001779A (pt) 1979-03-26 1980-03-25 Processo para inibir a secrecao de acido gastrico, composto particularmente eficaz para controlar secrecao gastrica e composicao farmaceutica para inibir a secrecao de acido gastrico e/ou tratar ulcera peptica em mamiferos

Country Status (31)

Country Link
US (1) US4343804A (https=)
JP (1) JPH02117663A (https=)
AR (1) AR230268A1 (https=)
AT (1) AT372373B (https=)
AU (1) AU528388B2 (https=)
BR (1) BR8001779A (https=)
CA (1) CA1147338A (https=)
CH (1) CH644105A5 (https=)
DE (1) DE3011490A1 (https=)
DK (1) DK156056C (https=)
EG (1) EG15009A (https=)
ES (1) ES8103048A1 (https=)
FI (1) FI77452C (https=)
FR (1) FR2452485B1 (https=)
GB (1) GB2047244B (https=)
GR (1) GR68006B (https=)
HK (1) HK67983A (https=)
IE (1) IE49577B1 (https=)
IL (1) IL59628A (https=)
IN (1) IN151446B (https=)
IT (1) IT1133079B (https=)
MX (1) MX6264E (https=)
NL (1) NL8001752A (https=)
NO (1) NO153927C (https=)
NZ (1) NZ193252A (https=)
PH (1) PH16416A (https=)
PL (1) PL125030B1 (https=)
PT (1) PT71008B (https=)
SE (1) SE435837B (https=)
SG (1) SG33683G (https=)
YU (1) YU41702B (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
CA2167154A1 (en) * 1993-08-10 1995-02-16 Sarkis Barret Kalindjian Gastrin and cck receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
IL142092A0 (en) 1998-09-29 2002-03-10 American Cyanamid Co Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
US6787534B2 (en) * 1999-12-28 2004-09-07 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
RS20060018A (sr) * 2003-07-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ, インコーポレイテッド (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス
EP3323818A1 (en) 2010-09-22 2018-05-23 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
SI3538512T1 (sl) 2016-11-11 2021-09-30 Bayer Animal Health Gmbh Novi antihelmintični kinolin-3-karboksamidni derivati
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
WO2019084271A1 (en) * 2017-10-25 2019-05-02 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE
US11572357B2 (en) 2018-05-09 2023-02-07 Bayer Animal Health Gmbh Quinoline derivatives
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
EP3959197A4 (en) 2019-04-24 2022-10-12 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (https=) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
AU5684880A (en) 1980-10-02
GB2047244B (en) 1983-02-23
SE435837B (sv) 1984-10-22
EG15009A (en) 1985-03-31
FI800910A7 (fi) 1980-09-27
NO153927C (no) 1986-06-18
IT1133079B (it) 1986-07-09
ATA156480A (de) 1983-02-15
IE800605L (en) 1980-09-26
GB2047244A (en) 1980-11-26
YU41702B (en) 1987-12-31
HK67983A (en) 1983-12-23
DE3011490A1 (de) 1981-03-12
PL222993A1 (https=) 1981-01-30
IL59628A (en) 1983-06-15
DE3011490C2 (https=) 1988-12-22
ES489887A0 (es) 1981-02-16
DK156056C (da) 1989-11-06
SG33683G (en) 1985-03-29
PT71008A (en) 1980-04-01
US4343804A (en) 1982-08-10
NO153927B (no) 1986-03-10
MX6264E (es) 1985-02-19
PT71008B (en) 1981-06-25
JPH02117663A (ja) 1990-05-02
CA1147338A (en) 1983-05-31
FI77452B (fi) 1988-11-30
AR230268A1 (es) 1984-03-01
FR2452485B1 (fr) 1986-09-12
IT8067465A0 (it) 1980-03-26
IN151446B (https=) 1983-04-23
IE49577B1 (en) 1985-10-30
GR68006B (https=) 1981-10-26
FI77452C (fi) 1989-03-10
DK128380A (da) 1980-09-27
ES8103048A1 (es) 1981-02-16
DK156056B (da) 1989-06-19
NZ193252A (en) 1984-04-27
YU84480A (en) 1983-10-31
AU528388B2 (en) 1983-04-28
PH16416A (en) 1983-09-29
CH644105A5 (fr) 1984-07-13
FR2452485A1 (fr) 1980-10-24
AT372373B (de) 1983-09-26
IL59628A0 (en) 1980-06-30
SE8002292L (sv) 1980-09-27
NL8001752A (nl) 1980-09-30
PL125030B1 (en) 1983-03-31
NO800858L (no) 1980-09-29

Similar Documents

Publication Publication Date Title
BR8001779A (pt) Processo para inibir a secrecao de acido gastrico, composto particularmente eficaz para controlar secrecao gastrica e composicao farmaceutica para inibir a secrecao de acido gastrico e/ou tratar ulcera peptica em mamiferos
BR8405797A (pt) Composto,composicao,processo para controlar vegetacao indesejada e processo para a preparacao do composto
BR7907849A (pt) Composto de piridino-sulfonamidas, composicao e processo para o controle de vegetacao indesejavel
BR8200758A (pt) Composicao endurecivel,processo para o endurecimento de resinas endureciveis por acido e emprego
BR8204789A (pt) Processo em batelada para preparar copolimeros
BR8103459A (pt) Composto,composicao e processo adequados para controlar o crescimento de vegetacao indesejavel
GB2153224B (en) Topical composition for treating acne
BR7904000A (pt) Compostos de acido silicico de precipitacao contendo boro,processo para a sua preparacao e emprego dos mesmos
BR8301246A (pt) Processo para produzir efeitos de corrosao brancos ou coloridos sobre materiais texteis
BR8306645A (pt) Processo para preparar produtos de adicao de monoeter e polieter poliol contendo acido caboxilico;produto de adicao de monoeter ou polieter poliol contendo acido carboxilico
BR8302396A (pt) Composto;composicao e processo adequados para controlar o crescimento de vegetacao indesejada
BR8504350A (pt) Processo para o tratamento de superficie de materiais ferrosos
BR8004382A (pt) Compostos herbicidas, composicao para o controle de vegetacao indesejavel e processo para controlar vegetacao indesejavel
BR7602012A (pt) Processo para tratamento preliminar de materiais para sinterizacao
BR8506413A (pt) Processo para a reducao do teor de cloro hidrolisavel em compostos de glicidila
EP0215956A4 (en) AGENTS FOR TREATING SKIN DISEASES.
BR8103009A (pt) Processo de preparacao de n-din-propilo-2,6-dinitro 4-trifluormetilanilina com baixo teor de nitrosaminas
BR8605587A (pt) Processo para producao de silicato ou metalossilicato em camadas e processo para preparacao de composicao de silicato ou metalossilicato em colunas
BR8703347A (pt) Composto ou um seu sal,processo para producao dos mesmos e composicao fungicida
BR8105336A (pt) Alfa-alenil-3-fenoxyibenzilester de acido ciclopropanocarboxilico, processo de preparacao e emprego
BR8304264A (pt) Compostos, composicao adequada e processo para controlar o crescimento de vegetacao indesejada
BR7905992A (pt) Processo para tratar materiais texteis
BR8108385A (pt) Processo para preparacao de acido sorbico,processo para conversao de acidos acetoxiexenoicos em acido sorbico e composicao
BR8307099A (pt) Esteres de acido n-metil-carbamico,processo para sua preparacao,composicao praguicida e emprego
BR8102506A (pt) Composicao para tratar materiais texteis, processo para sua preparacao, processo para tratar materiais texteis e materiais texteis revestidos